What we do
We are committed to perform cutting edge patient care, research and teaching and to enable these activities by curiosity-driven and clinic-driven laboratory and clinical research that is ambitious and of high scientific quality.
Research
Our research program ranges from fundamental biology to clinical translation and aims to improve diagnostics and treatment in immune-related diseases, including transplant rejection, immunodeficiency, autoimmunity and cancer.
News
-
-
Biomarkers discovered that may predict whether immunotherapy will work in cancer patients
-
CD4+ helper T cells endow cDC1 with cancer-impeding functions in the human tumor micro-environment
-
A novel approach to identify cancer-specific T helper antigens
-
Honorary doctorate awarded to Jacques van Dongen during festive ceremony in Prague
-
Inspiring IMMU Science Retreat with many visitors